Minocycline
Minocycline is a pharmaceutical drug with 140 clinical trials. Currently 7 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 84 completed trials
Phase Distribution
Phase Distribution
38
Early Stage
45
Mid Stage
41
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.6%
84 of 103 finished
18.4%
19 ended early
7
trials recruiting
140
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Stony Brook Medicine Anti-Inflammatory Trial
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Minocycline as Adjunctive Treatment for Treatment Resistant Depression
Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Clinical Trials (140)
Stony Brook Medicine Anti-Inflammatory Trial
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Minocycline as Adjunctive Treatment for Treatment Resistant Depression
Reconsolidation Blockade of Intrusive Trauma- and Cocaine-related Memories
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Efficacy and Safety of Minocycline in the Treatment of Intracerebral Hemorrhage
Maimonides Minocycline in Stroke Study
Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration
Minocyclin in Ulcerative Colitis as Added on Therapy
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy
Minocycline as Neuroprotectant After Aneurysmal Subarachnoid Hemorrhage
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
Study 3: Minocycline Decreases Microglia Activation
Pharmacokinetic Study of Minocycline in Patients With Pulmonary Nontuberculous Mycobacterial Disease
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54175446 in Healthy Male Participants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 140